The Functional-Organic Dichotomy: Postinfectious Irritable Bowel Syndrome and Inflammatory Bowel Disease-Irritable Bowel Syndrome

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 1, 2009, Pages 48-53

  Grover, Madhusudan ^a,c   Herfarth, Hans ^a,b   Drossman, Douglas A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISTRESS SYNDROME; ENTERITIS; GASTROINTESTINAL INFECTION; GENETIC PREDISPOSITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DYSREGULATION; INTESTINE FLORA; IRRITABLE COLON; MENTAL STRESS; PATHOPHYSIOLOGY; POSTINFECTIOUS IRRITABLE BOWEL SYNDROME; RISK FACTOR;

HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME;

EID: 58049213782     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.08.032     Document Type: Article

References (88)

1. Drossman D.A. Functional GI disorders: what's in a name?. Gastroenterology 128 (2005) 1771-1772
2. Quigley E.M. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?. Chin J Dig Dis 6 (2005) 122-132
3. Drossman D.A. Functional versus organic: an inappropriate dichotomy for clinical care. Am J Gastroenterol 101 (2006) 1172-1175
4. Chaudhary N.A., and Truelove S.C. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. QJM 31 (1962) 307-322
5. Halvorson H.A., Schlett C.D., and Riddle M.S. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 101 (2006) 1894-1899
6. Marshall J.K., Thabane M., Garg A.X., et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 131 (2006) 445-450
7. Marshall J.K., Thabane M., Borgaonkar M.R., et al. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 5 (2007) 457-460
8. Neal K.R., Hebden J., and Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 314 (1997) 779-782
9. Dunlop S.P., Jenkins D., Neal K.R., et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125 (2003) 1651-1659
10. Gwee K.A., Graham J.C., McKendrick M.W., et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 347 (1996) 150-153
11. Gwee K.A., Leong Y.L., Graham C., et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44 (1999) 400-406
12. Gwee K.A., Collins S.M., Read N.W., et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 52 (2003) 523-526
13. Spiller R.C., Jenkins D., Thornley J.P., et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47 (2000) 804-811
14. Dunlop S.P., Jenkins D., and Spiller R.C. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 98 (2003) 1578-1583
15. Wang L.H., Fang X.C., and Pan G.Z. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53 (2004) 1096-1101
16. Marshall J.K., Thabane M., Garg A.X., et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 20 (2004) 1317-1322
17. Barbara G., Wang B., Stanghellini V., et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132 (2007) 26-37
18. Barbara G., Stanghellini V., DeGiorgio R., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004) 693-702
19. Drossman D.A. Mind over matter in the postinfective irritable bowel. Gut 44 (1999) 306-307
20. Soderholm J.D., Yang P.C., Ceponis P., et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123 (2002) 1099-1108
21. Soderholm J.D., and Perdue M.H. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 280 (2001) G7-G13
22. Drossman D.A. Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists. Gut 54 (2005) 569-573
23. Jones M.P., Dilley J.B., Drossman D., et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 18 (2006) 91-103
24. Levy R.L., Olden K.W., Naliboff B.D., et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130 (2006) 1447-1458
25. Saito Y.A., Schoenfeld P., and Locke III G.R. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 97 (2002) 1910-1915
26. Bayless T.M., and Harris M.L. Inflammatory bowel disease and irritable bowel syndrome. Med Clin North Am 74 (1990) 21-28
27. Simren M., Axelsson J., Gillberg R., et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97 (2002) 389-396
28. Farrokhyar F., Marshall J.K., Easterbrook B., et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 12 (2006) 38-46
29. Shen B., Achkar J.P., Lashner B.A., et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 97 (2002) 972-977
30. Isgar B., Harman M., Kaye M.D., et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 24 (1983) 190-192
31. Minderhoud I.M., Oldenburg B., Wismeijer J.A., et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 49 (2004) 469-474
32. Maunder R.G., and Greenberg G.R. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis. Inflamm Bowel Dis 10 (2004) 632-636
33. Rizzello F., Gionchetti P., Venturi A., et al. Review article: monitoring activity in ulcerative colitis. Aliment Pharmacol Ther 16 Suppl 4 (2002) 3-6
34. Kern F., Almy T.P., Abbot F.K., et al. The motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology 19 (1951) 492-505
35. Snape Jr. W.J., Williams R., and Hyman P.E. Defect in colonic smooth muscle contraction in patients with ulcerative colitis. Am J Physiol 261 (1991) G987-G991
36. Annese V., Bassotti G., Napolitano G., et al. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 32 (1997) 1107-1117
37. Minderhoud I.M., Smout A.J., Oldenburg B., et al. A pilot study on chemospecific duodenal visceral sensitivity in inflammatory bowel disease in remission. Digestion 73 (2006) 151-159
38. Rao S.S., and Read N.W. Gastrointestinal motility in patients with ulcerative colitis. Scand J Gastroenterol Suppl 172 (1990) 22-28
39. Farthing M.J., and Lennard-Jones J.E. Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut 19 (1978) 64-69
40. Minderhoud I.M., Oldenburg B., Schipper M.E., et al. Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin Gastroenterol Hepatol 5 (2007) 714-720
41. Greenwood-Van Meerveld B. Importance of 5-hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity. Neurogastroenterol Motil 19 (2007) 13-18
42. Mawdsley J.E., Macey M.G., Feakins R.M., et al. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 131 (2006) 410-419
43. Talal A.H., and Drossman D.A. Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin North Am 24 (1995) 699-716
44. Garrett J.W., and Drossman D.A. Health status in inflammatory bowel disease. Biological and behavioral considerations. Gastroenterology 99 (1990) 90-96
45. Drossman D.A., Leserman J., Mitchell C.M., et al. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci 36 (1991) 1746-1755
46. Mittermaier C., Dejaco C., Waldhoer T., et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66 (2004) 79-84
47. Hisamatsu T., Inoue N., Yajima T., et al. Psychological aspects of inflammatory bowel disease. J Gastroenterol 42 Suppl 17 (2007) 34-40
48. Drossman D.A. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med 60 (1998) 258-267
49. Mardini H.E., Kip K.E., and Wilson J.W. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 49 (2004) 492-497
50. Kurina L.M., Goldacre M.J., Yeates D., et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 55 (2001) 716-720
51. Schwarz S.P., and Blanchard E.B. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 29 (1991) 167-177
52. Farrell R.J., and Peppercorn M.A. Ulcerative colitis. Lancet 359 (2002) 331-340
53. Mawdsley J.E., and Rampton D.S. The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 13 (2006) 327-336
54. Ringel Y., and Drossman D.A. Psychosocial aspects of Crohn's disease. Surg Clin North Am 81 (2001) 231-252 x
55. Cenac N., Chin A.C., Garcia-Villar R., et al. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J Physiol 558 (2004) 913-925
56. Neunlist M., Aubert P., Toquet C., et al. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 52 (2003) 84-90
57. Barbara G., Vallance B.A., and Collins S.M. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 113 (1997) 1224-1232
58. Barbara G., De G.R., Deng Y., et al. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 120 (2001) 1729-1736
59. Farhadi A., Fields J.Z., and Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 13 (2007) 3027-3030
60. Tagore A., Gonsalkorale W.M., Pravica V., et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 54 (1999) 386-390
61. Gonsalkorale W.M., Perrey C., Pravica V., et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?. Gut 52 (2003) 91-93
62. Meddings J.B. Review article: intestinal permeability in Crohn's disease. Aliment Pharmacol Ther 11 Suppl 3 (1997) 47-53
63. Mayer E.A., Naliboff B.D., Chang L., et al. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 280 (2001) G519-G524
64. Heitkemper M., Jarrett M., Cain K., et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol 91 (1996) 906-913
65. Bohmelt A.H., Nater U.M., Franke S., et al. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 67 (2005) 288-294
66. Fukudo S., Nomura T., and Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 42 (1998) 845-849
67. Dinan T.G., Quigley E.M., Ahmed S.M., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 130 (2006) 304-311
68. Posserud I., Agerforz P., Ekman R., et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 53 (2004) 1102-1108
69. Elsenbruch S., and Orr W.C. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol 96 (2001) 460-466
70. Tache Y., and Perdue M.H. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 16 Suppl 1 (2004) 137-142
71. Kawahito Y., Sano H., Mukai S., et al. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37 (1995) 544-551
72. Sagami Y., Shimada Y., Tayama J., et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53 (2004) 958-964
73. Camilleri M., and Ford M.J. Functional gastrointestinal disease and the autonomic nervous system: a way ahead?. Gastroenterology 106 (1994) 1114-1118
74. Qiu B.S., Vallance B.A., Blennerhassett P.A., et al. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 5 (1999) 1178-1182
75. Murray C.D., Flynn J., Ratcliffe L., et al. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 127 (2004) 1695-1703
76. Emmanuel A.V., Mason H.J., and Kamm M.A. Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder. Gut 49 (2001) 209-213
77. Evans P.R., Bak Y.T., Shuter B., et al. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci 42 (1997) 2087-2093
78. Welgan P., Meshkinpour H., and Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 94 (1988) 1150-1156
79. Barclay G.R., and Turnberg L.A. Effect of psychological stress on salt and water transport in the human jejunum. Gastroenterology 93 (1987) 91-97
80. Taylor C.T., and Keely S.J. The autonomic nervous system and inflammatory bowel disease. Auton Neurosci 133 (2007) 104-114
81. Adeyemi E.O., Desai K.D., Towsey M., et al. Characterization of autonomic dysfunction in patients with irritable bowel syndrome by means of heart rate variability studies. Am J Gastroenterol 94 (1999) 816-823
82. Waring W.S., Chui M., Japp A., et al. Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol 38 (2004) 658-663
83. Lee C.T., Chuang T.Y., Lu C.L., et al. Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study. Dig Dis Sci 43 (1998) 1794-1799
84. Elsenbruch S., Holtmann G., Oezcan D., et al. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome?. Am J Gastroenterol 99 (2004) 703-710
85. Ginsburg P.M., and Bayless T.M. Managing functional disturbances in patients with inflammatory bowel disease. Curr Treat Options Gastroenterol 8 (2005) 211-221
86. Drossman D.A., Toner B.B., Whitehead W.E., et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125 (2003) 19-31
87. Mawdsley J.E., Jenkins D.G., Macey M.G., et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 103 (2008) 1460-1469
88. Ringel Y., Drossman D.A., Leserman J.L., et al. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an fMRI study. Gastroenterology 134 (2008) 396-404